These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1082545

  • 1. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B, Biniaminov M, Shoham C, Rosenthal E.
    N Engl J Med; 1976 Apr 08; 294(15):809-11. PubMed ID: 1082545
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of advanced Hodgkin's disease in remission.
    Klener P, Hausner P, Donner L.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Apr 08; 109(2):213-7. PubMed ID: 6179821
    [Abstract] [Full Text] [Related]

  • 8. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
    Fuks Z, Strober S, King DP, Kaplan HS.
    J Immunol; 1976 Oct 08; 117(4):1331-5. PubMed ID: 1086325
    [Abstract] [Full Text] [Related]

  • 9. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM, Fuks Z, Kaplan HS.
    Clin Exp Immunol; 1977 Sep 08; 29(3):369-75. PubMed ID: 201408
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T, Jakab L, Fehér J, Cseh K.
    Allergol Immunopathol (Madr); 1982 Sep 08; 10(6):435-9. PubMed ID: 6220589
    [Abstract] [Full Text] [Related]

  • 13. The effect of levamisole on E-rosette formation by trypsinized lymphocytes.
    Lomnitzer R, Rabson AR.
    Clin Exp Immunol; 1978 Sep 08; 33(3):499-502. PubMed ID: 310743
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R, Many A, Ramot B, Trainin N.
    Clin Exp Immunol; 1978 Jan 08; 31(1):111-5. PubMed ID: 639342
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interference of levamisole with inhibition of E-rosette formation by Hodgkin's disease and systemic lupus erythematosus cytotoxic sera.
    Del Giacco GS, Tognella S, Leone AL, Locci F, Cornaglia P, Sangiuolo A, Grifoni V.
    Blood; 1979 May 08; 53(5):1002-6. PubMed ID: 435634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.